Annals of Internal Medicine
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)
2021
-
Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
174:W66-W67.
2021
-
In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups.
174:JC94-JC94.
2021
-
The Development of Living, Rapid Practice Points: Summary of Methods From the Scientific Medical Policy Committee of the American College of Physicians.
174:1126-1132.
2021
-
Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians.
174:985-993.
2021
-
Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons?.
174:889-898.
2021
-
In COVID-19, tocilizumab reduces all-cause mortality at 28 d.
174:JC63-JC63.
2021
-
In HFrEF, adding empagliflozin to medical therapy reduced a composite outcome, regardless of CKD status.
174:JC68-JC68.
2021
-
What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 1).
174:828-835.
2021
-
Clinical Practice Guidelines Registry: Toward Reducing Duplication, Improving Collaboration, and Increasing Transparency.
174:705-707.
2021
-
In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
174:JC50-JC50.
2021
-
Nonpharmacologic and Pharmacologic Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries in Adults.
174:733-733.
2021
-
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
174:673-679.
2021
-
Clinician Perspectives on Caring for Dying Patients During the Pandemic.
174:493-500.
2021
-
Cloth Masks May Prevent Transmission of COVID-19.
174:580-580.
2021
-
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y.
174:JC45-JC45.
2021
-
Joint testing of IgM and IgG has high value for ruling in SARS-CoV-2 infection.
174:JC47-JC47.
2021
-
Annals for Hospitalists Inpatient Notes - Timely Hip Fracture Surgery.
174:HO2-HO3.
2021
-
In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
174:JC29-JC29.
2021
-
In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.
174:JC28-JC28.
2021
-
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1).
174:229-236.
2021
-
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.
174:JC15-JC15.
2021
-
Tocilizumab did not reduce hypoxemic respiratory failure or death in hospitalized patients with COVID-19.
174:JC16-JC16.
2021
-
Developing Guidelines Before, During, and After the COVID-19 Pandemic.
173:1012-1014.
2020
-
Update Alert: Use of N95, Surgical, or Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1).
173:170-170.
2020
-
Update Alert 2: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
173:W152-W153.
2020
-
Chest ultrasonography by frontline physicians is more sensitive than CXR for diagnosing pneumothorax in trauma patients.
173:JC58-JC58.
2020
-
Point-of-care ultrasonography had 92% sensitivity and 97% specificity for diagnosing diverticulitis in the ED.
173:JC59-JC59.
2020
-
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
173:860-860.
2020
-
Association Between Bariatric Surgery and All-Cause Mortality: A Population-Based Matched Cohort Study in a Universal Health Care System.
173:694-703.
2020
-
Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries.
173:730-738.
2020
-
Predictors of Prolonged Opioid Use After Initial Prescription for Acute Musculoskeletal Injuries in Adults.
173:721-729.
2020
-
USPSTF recommends asking adults screening questions about unhealthy drug use.
173:JC38-JC38.
2020
-
Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1).
173:642-649.
2020
-
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach.
173:489-491.
2020
-
The Value of Large Randomized Trials of Two Active Interventions to Define the Optimal Treatment in Patients With Acute Coronary Syndrome.
173:494-495.
2020
-
Update Alert: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
173:W122-W122.
2020
-
Vericiguat reduced a composite of CV death or HF hospitalization in patients with HF and reduced LVEF.
173:JC30-JC30.
2020
-
Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
173:W88-W89.
2020
-
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
173:204-216.
2020
-
Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1).
173:137-142.
2020
-
Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
173:W48-W51.
2020
-
Breast Cancer Screening and Diagnosis.
172:840-841.
2020
-
Preoperative N-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
172:843-843.
2020
-
Context and Approach in Reporting Evaluations of Electronic Health Record–Based Implementation Projects.
172:S73-S78.
2020
-
Unprocessed Red Meat and Processed Meat Consumption.
172:639-640.
2020
-
Pooled RCTs: In patients with HF in sinus rhythm, β-blockers reduced mortality at GFR ≥ 30 mL/min/1.73 m2.
172:JC38-JC38.
2020
-
Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes.
172:511-511.
2020
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults.
172:508-508.
2020
-
Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fraction.
172:JC16-JC16.
2020
-
In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.
172:JC5-JC5.
2020
-
In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.
172:JC4-JC4.
2020
-
Oral fluoroquinolone was linked to mitral and aortic regurgitation compared with amoxicillin or azithromycin.
172:JC10-JC10.
2020
-
Preoperative N-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery.
172:96-96.
2020
-
Testosterone Treatment in Adult Men With Age-Related Low Testosterone: A Clinical Guideline From the American College of Physicians.
172:126-126.
2020
-
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines.
172:46-46.
2020
-
Compassionate End-of-Life Care: Mixed-Methods Multisite Evaluation of the 3 Wishes Project.
172:1-1.
2020
-
Development of the European Commission Initiative on Breast Cancer Guidelines.
172:72-72.
2020
-
Bedside Optic Nerve Ultrasonography for Diagnosing Increased Intracranial Pressure.
171:896-896.
2019
-
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group.
171:805-805.
2019
-
Effect of Lower Versus Higher Red Meat Intake on Cardiometabolic and Cancer Outcomes.
171:721-721.
2019
-
Health-Related Values and Preferences Regarding Meat Consumption.
171:742-742.
2019
-
In primary care, CRP testing reduced antibiotic use in COPD exacerbations without worsening health.
171:JC51-JC51.
2019
-
Patterns of Red and Processed Meat Consumption and Risk for Cardiometabolic and Cancer Outcomes.
171:732-732.
2019
-
Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes.
171:703-703.
2019
-
Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence.
171:711-711.
2019
-
Review: After PCI with DESs, long- and standard-term DAPT increase some adverse outcomes vs short-term DAPT.
171:JC54-JC54.
2019
-
Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium.
171:756-756.
2019
-
Annals Story Slam - What's a Life Worth?.
171:SS1-SS1.
2019
-
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians.
171:643-643.
2019
-
Annals On Call - Making Sense of Breast Cancer Screening Guidelines.
171:OC1-OC1.
2019
-
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males.
171:540-540.
2019
-
Pantoprazole did not reduce risk for a composite of upper gastrointestinal events in stable arterial disease.
171:JC45-JC45.
2019
-
Annals for Hospitalists Inpatient Notes - Rethinking Oxygen Therapy for Hospitalized Patients.
171:HO2-HO2.
2019
-
Screening for Breast Cancer in Average-Risk Women.
171:451-451.
2019
-
Cardiac Device Implantation Complications: A Gap in the Quality of Care?.
171:368-368.
2019
-
Methods for Development of the European Commission Initiative on Breast Cancer Guidelines.
171:273-273.
2019
-
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease.
171:181-181.
2019
-
Review: Nonpharmacologic and pharmacologic interventions improve urinary incontinence in women.
171:JC3-JC3.
2019
-
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure.
171:76-76.
2019
-
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days.
170:JC67-JC67.
2019
-
Pooled RCTs: Lowering LDL-C levels using statins reduces major vascular events in all age groups.
170:JC65-JC65.
2019
-
The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods.
170:863-863.
2019
-
In type 2 diabetes with periodontitis, intensive periodontitis treatment improved glycemic control at 1 year.
170:JC40-JC40.
2019
-
Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians.
170:547-547.
2019
-
In patients with previous dilated cardiomyopathy, withdrawal of HF drugs increased relapse at 6 months.
170:JC28-JC28.
2019
-
A wearable cardioverter–defibrillator did not reduce arrhythmic death in MI with reduced ejection fraction.
170:JC5-JC5.
2019
-
Management of out-of-hospital cardiac arrest with laryngeal tube improved survival vs endotracheal intubation.
170:JC4-JC4.
2019
-
The Potential for Troponin to Inform Prognosis in Patients With Stable Coronary Artery Disease.
169:808-808.
2018
-
In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not.
169:JC54-JC54.
2018
-
Pregabalin and the Risk for Opioid-Related Death: A Nested Case–Control Study.
169:732-732.
2018
-
Review: Evidence is inconclusive on metabolic surgery vs medical treatment for microvascular complications in T2DM.
169:JC9-JC9.
2018
-
In high-risk T1DM, real-time continuous glucose monitoring vs self-monitoring reduced hypoglycemic events.
168:JC53-JC53.
2018
-
In hospitalized adults with polypharmacy, a multifaceted pharmacist intervention reduced readmissions at 180 days.
168:JC59-JC59.
2018
-
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer.
168:459-459.
2018
-
Review: Multilevel and patient-level implementation strategies reduce BP more than usual care in hypertension.
168:JC29-JC29.
2018
-
Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery.
168:237-237.
2018
-
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms.
168:JC23-JC23.
2018
-
Prognostic Accuracy of the Quick Sequential Organ Failure Assessment for Mortality in Patients With Suspected Infection.
168:266-266.
2018
-
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.
169:467-473.
2018
-
After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy.
167:JC70-JC70.
2017
-
Review: In HF with preserved EF, β-blockers reduced mortality; drug treatment overall did not.
167:JC68-JC68.
2017
-
In localized prostate cancer, radical prostatectomy and observation did not differ for mortality at 13 years.
167:JC53-JC53.
2017
-
Your Money or Your Patient's Life? Ransomware and Electronic Health Records.
167:587-587.
2017
-
4 hs-cTnI algorithms had high sensitivity and low failure rates for ruling out acute MI in the ED.
167:JC35-JC35.
2017
-
HERDOO2 identified women at low risk for recurrence after 5 to 12 mo of anticoagulation for a first unprovoked VTE.
167:JC33-JC33.
2017
-
High-STEACS Algorithm missed fewer patients with acute MI than the ESC Pathway in the ED.
167:JC34-JC34.
2017
-
In knee OA, intraarticular triamcinolone increased cartilage loss and did not differ from saline for knee pain.
167:JC27-JC27.
2017
-
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer.
167:341-341.
2017
-
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding.
167:JC17-JC17.
2017
-
In older adults with subclinical hypothyroidism, levothyroxine did not improve symptoms or tiredness.
167:JC14-JC14.
2017
-
Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia.
167:170-170.
2017
-
Computer-Aided Systematic Review Screening Comes of Age.
167:210-210.
2017
-
Guidelines to Limit Added Sugar Intake.
167:219-219.
2017
-
The Scientific Basis of Guideline Recommendations on Sugar Intake.
167:219-219.
2017
-
Aspirin plus clopidogrel was not linked to risk for cancer compared with aspirin alone or no antiplatelets.
167:JC10-JC10.
2017
-
In patients receiving DAPT after coronary stents, the PRECISE-DAPT score predicted bleeding moderately well.
167:JC11-JC11.
2017
-
An online exercise program plus automated coping skills training improved pain and function in chronic knee pain.
166:JC67-JC67.
2017
-
In severe aortic stenosis with intermediate surgical risk, TAVR was noninferior to SAVR for death or disabling stroke.
166:JC68-JC68.
2017
-
Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality.
166:JC70-JC70.
2017
-
Does Knowledge of the Coronary Anatomy Save Lives in Patients With Unstable Angina?.
166:848-848.
2017
-
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding.
166:JC29-JC29.
2017
-
In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo.
166:JC32-JC32.
2017
-
PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery.
166:JC35-JC35.
2017
-
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
166:279-279.
2017
-
Primary Care Physician Volume and Quality of Diabetes Care.
166:240-240.
2017
-
The Scientific Basis of Guideline Recommendations on Sugar Intake.
166:257-257.
2017
-
In older adults with COPD, new opioid use was linked to increased risk for respiratory and all-cause mortality.
166:JC11-JC11.
2017
-
In patients with severe sepsis, hydrocortisone did not prevent progression to septic shock.
166:JC10-JC10.
2017
-
Review: Some drugs, added to hydration, prevent contrast-induced acute kidney injury.
166:JC9-JC9.
2017
-
A reporting tool for practice guidelines in health care: the RIGHT statement.
166:128-132.
2017
-
Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children.
165:617-617.
2016
-
4 risk assessment models had good calibration but poor discrimination for VTE in hospitalized medical patients.
165:JC35-JC35.
2016
-
Review: In severe aortic stenosis, TAVI and conventional surgery do not differ for ≤ 30-day or ≤ 1-year mortality.
165:JC31-JC31.
2016
-
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk.
165:JC8-JC8.
2016
-
Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians.
165:125-125.
2016
-
Principles for Disclosure of Interests and Management of Conflicts in Guidelines: Desirable and Undesirable Action and Consequences.
164:702-702.
2016
-
Transition care with telemonitoring did not reduce readmission after hospitalization for heart failure.
164:JC59-JC59.
2016
-
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia.
164:636-636.
2016
-
The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease.
164:472-472.
2016
-
Evidence-Based Guideline: ACR made 10 strong treatment recommendations for RA, but high-quality evidence was sparse.
164:JC27-JC27.
2016
-
Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF.
164:JC33-JC33.
2016
-
In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk.
164:JC10-JC10.
2016
-
In HIV-1, immediate vs deferred antiretroviral therapy and isoniazid vs no isoniazid reduced severe illness at 30 mo.
163:JC5-JC5.
2015
-
In early HIV infection, immediate vs deferred antiretroviral therapy reduced serious illnesses at 3 years.
163:JC4-JC4.
2015
-
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia.
163:519-528.
2015
-
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines.
163:548-553.
2015
-
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality.
163:409-416.
2015
-
How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society.
163:382-385.
2015
-
Baseline plus 1-hour high-sensitivity cardiac troponin T improved early rule-out and rule-in of acute MI.
163:JC12-JC12.
2015
-
Personalizing Death in the Intensive Care Unit: The 3 Wishes Project.
163:271-279.
2015
-
Baseline plus 1-hour high-sensitivity cardiac troponin T improved early rule-out and rule-in of acute MI.
163:JC12-JC12.
2015
-
David Lawrence Sackett, MD, MSc (Epidemiology), 1934–2015.
163:JC2-JC2.
2015
-
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement.
163:118-126.
2015
-
Use of long-acting, vs short-acting, opioids for chronic pain was linked to unintentional overdose.
163:JC11-JC11.
2015
-
ACP Journal Club. In STEMI, manual thrombectomy before PCI did not reduce CV-related outcomes but increased stroke..
162:JC2.
2015
-
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations.
162:777-784.
2015
-
In hospitalized patients, an electronic alert for acute kidney injury did not differ from usual care.
162:JC6-JC6.
2015
-
d-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism.
162:671-671.
2015
-
In acute ischemic stroke, early intraarterial treatment plus usual care improved functional independence.
162:JC2-JC2.
2015
-
In acute ischemic stroke, rapid intraarterial treatment plus usual care improved functional independence.
162:JC3-JC3.
2015
-
In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome.
162:JC4-JC4.
2015
-
Review: In peri- or postmenopausal women, DHEA does not improve symptoms and increases androgenic side effects.
162:JC9-JC9.
2015
-
Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation.
162:JC4-JC4.
2015
-
Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants.
162:JC3-JC3.
2015
-
Cervical Spine Clearance in Obtunded Patients After Blunt Traumatic Injury.
162:429-437.
2015
-
Dual antiplatelets for 30 mo after drug-eluting stents reduced stent thrombosis and CV and cerebrovascular events.
162:JC9-JC9.
2015
-
Albumin Administration in Patients With Sepsis.
162:319-320.
2015
-
d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy.
162:27-34.
2015
-
In suspected nephrolithiasis, US did not differ from CT for high-risk diagnoses but reduced radiation exposure.
162:JC4-JC4.
2015
-
Review: Fiber supplementation improves symptoms in the irritable bowel syndrome.
161:JC10-JC10.
2014
-
Review: In sepsis, the effect of resuscitation with crystalloid and colloid fluids on mortality varies.
161:JC12-JC12.
2014
-
Review: In pulmonary embolism, thrombolytic therapy reduces all-cause mortality but increases major bleeding.
161:JC9-JC9.
2014
-
Fluid Resuscitation in Sepsis.
161:347-347.
2014
-
Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults.
161:242-242.
2014
-
Methotrexate reduced pain and improved function in symptomatic knee osteoarthritis.
161:JC6-JC6.
2014
-
Review: Natriuretic peptide–guided therapy reduces mortality more than clinically guided therapy in heart failure.
161:JC10-JC10.
2014
-
In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age.
160:JC7-JC7.
2014
-
Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non–ST-elevation ACS.
160:JC9-JC9.
2014
-
In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2and CHA2DS2-VASc.
160:JC13-JC13.
2014
-
Live kidney donation was associated with increased mortality and end-stage renal disease at 15 years.
160:JC12-JC12.
2014
-
Review: Calprotectin testing differentiates inflammatory bowel disease from the irritable bowel syndrome.
160:JC13-JC13.
2014
-
Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria.
160:JC3-JC3.
2014
-
Review: New oral anticoagulants increase GI bleeding in venous thrombosis and ACS.
160:JC4-JC4.
2014
-
Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation.
160:JC3-JC3.
2014
-
Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline.
160:182-189.
2014
-
Methylprednisolone injections reduced carpal tunnel syndrome symptoms at 10 weeks and surgery at 1 year.
160:JC11-JC11.
2014
-
Review: Bariatric surgery increases weight loss and diabetes remission more than nonsurgical treatment.
160:JC7-JC7.
2014
-
In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke..
161:JC8-JC8.
2014
-
Crohn disease was not associated with increased risk for mortality.
159:JC12-JC12.
2013
-
Review: Probiotics preventC. difficile–associated diarrhea in patients using antibiotics.
159:JC7-JC7.
2013
-
Statin Toxicity From Macrolide Antibiotic Coprescription.
159:575-575.
2013
-
Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic embolism.
159:JC5-JC5.
2013
-
Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke.
159:JC4-JC4.
2013
-
Review: Treatment options for asymptomatic carotid artery stenosis were compared.
159:JC6-JC6.
2013
-
Review: Routine venous thromboembolism prophylaxis in hospitalized frail older patients has uncertain benefit.
159:JC9-JC9.
2013
-
Statin Toxicity From Macrolide Antibiotic Coprescription.
158:869-869.
2013
-
Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty.
158:800-800.
2013
-
Commentary.
158.
2013
-
Review: Blood transfusions are associated with higher mortality than no or restricted transfusions in MI.
158:JC13-JC13.
2013
-
Review: Nutritional supplementation has uncertain effects on patient-important outcomes in COPD.
158:JC5-JC5.
2013
-
Review: Probiotics reduceClostridium difficile–associated diarrhea in patients receiving antibiotics.
158:JC10-JC10.
2013
-
Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea.
158:706-706.
2013
-
Adding renal dysfunction to CHADS2did not improve prediction of stroke or systemic embolism in AF.
158:JC13-JC13.
2013
-
Commentary.
158:13.
2013
-
Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolism.
158:JC2-JC2.
2013
-
Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults.
158:447-447.
2013
-
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma.
158:329-329.
2013
-
The PLAN score predicted death and severe disability in patients with acute ischemic stroke.
158:JC13-JC13.
2013
-
Commentary.
158.
2013
-
Review: Case management reduces mortality and HF readmissions in patients with HF.
158:JC11-JC11.
2013
-
Selectived-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis.
158:93-93.
2013
-
Probiotics for the Prevention ofClostridium difficile–Associated Diarrhea.
157:878-878.
2012
-
Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention.
157:817-817.
2012
-
rt-PA within 6 hours of acute ischemic stroke did not improve clinical outcomes at 6 months.
157:JC5-JC5.
2012
-
Screening Women for Intimate Partner Violence.
157:676-676.
2012
-
Review: Oseltamivir relieves symptoms but does not reduce hospitalizations in influenza.
157:JC3-JC3.
2012
-
Antivirals for Treatment of Influenza.
157:386-386.
2012
-
Effects of Excessive Fructose Intake on Health.
156:905-905.
2012
-
Effects of Excessive Fructose Intake on Health.
156:905-905.
2012
-
Hypnotic drugs were associated with increased risk for mortality.
156:JC6-JC6.
2012
-
Review: Perioperative statins reduce perioperative MI and AF in statin-naïve patients.
156:JC6-JC6.
2012
-
Conflicts of Interest Ethics: Silencing Expertise in the Development of International Clinical Practice Guidelines.
156:809-809.
2012
-
IV salbutamol increased mortality in patients with the acute respiratory distress syndrome.
156:JC5-JC5.
2012
-
Inviting Patients to Read Doctors' Notes.
156:608-608.
2012
-
Effect of Fructose on Body Weight in Controlled Feeding Trials.
156:291-291.
2012
-
Effects of School Closure on Incidence of Pandemic Influenza in Alberta, Canada.
156:173-173.
2012
-
Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database.
156:195-195.
2012
-
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.
156:512-524.
2012
-
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
156:710-719.
2012
-
Correction: Whole-Body Vibration.
155:860-860.
2011
-
Effect of 12 Months of Whole-Body Vibration Therapy on Bone Density and Structure in Postmenopausal Women.
155:668-668.
2011
-
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial.
155:660-660.
2011
-
Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios.
155:653-653.
2011
-
Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable.
155:579-579.
2011
-
Outpatient treatment was noninferior to inpatient treatment for preventing recurrent VTE in low-risk patients with acute PE.
155:JC4-JC4.
2011
-
Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery.
155:477-477.
2011
-
Annual screening with CA-125 and transvaginal ultrasonography did not reduce ovarian cancer incidence or mortality.
155:JC3-JC3.
2011
-
Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda.
155:209-209.
2011
-
Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
155:179-179.
2011
-
Dalteparin did not differ from unfractionated heparin for reducing proximal DVT in critically ill patients.
155.
2011
-
Commentary.
154:31-36.
2011
-
The Cardiovascular Health Awareness Program reduced CV hospitalizations but not mortality in older adults.
154:JC6-JC6.
2011
-
The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care.
154:JC6-JC6.
2011
-
Rates of Kidney Transplantation in Nations With Presumed Consent.
154:778-778.
2011
-
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions.
154:JC5-JC5.
2011
-
Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment.
154:JC5-JC5.
2011
-
Assessment of Recurrence Risk After Unprovoked Venous Thromboembolism.
154:644-644.
2011
-
Cholera Epidemic in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of Disease and Identify Optimal Control Interventions.
154:593-593.
2011
-
Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery.
154:523-523.
2011
-
Review: Ultrasonography is accurate for diagnosing rotator cuff tears in adults.
154:JC4-JC4.
2011
-
Should Patients With Stroke Wear Compression Stockings?.
154:506-506.
2011
-
Update in Hematology and Oncology: Evidence Published in 2010.
154:487-487.
2011
-
Hormone therapy increased risk for kidney stones in healthy postmenopausal women.
154:JC3-JC3.
2011
-
Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk.
154:310-310.
2011
-
Review: Topical nitroglycerin reduces pain during ADL in patients with chronic tendinopathies.
154:JC2-JC2.
2011
-
Review: Positive D-dimer results predict recurrence after first unprovoked VTE regardless of test timing or cutpoint, or patient age.
154:JC1-JC1.
2011
-
In response.
154:506.
2011
-
Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease.
153.
2010
-
Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease.
153:JC5-JC5.
2010
-
Informing the Debate: Rates of Kidney Transplantation in Nations With Presumed Consent.
153:641-641.
2010
-
Informing the Debate: Rates of Kidney Transplantation in Nations With Presumed Consent.
153:641-649.
2010
-
Should Patients With Stroke Wear Compression Stockings to Prevent Venous Thromboembolism?.
153:610-610.
2010
-
A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis.
153:JC4-JC4.
2010
-
Individual and combined confrontation visual field tests performed poorly as a screen for visual field abnormalities.
153:JC4-JC4.
2010
-
Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability ofd-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism.
153:523-523.
2010
-
In response.
153:422.
2010
-
Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AF.
153:JC2-JC2.
2010
-
Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility.
153:8-8.
2010
-
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease.
153:23-23.
2010
-
Review: Evidence on the effectiveness of sodium bicarbonate regimens to prevent contrast-induced nephropathy is unclear.
152:JC5-JC5.
2010
-
On-demand ordering of chest radiographs reduced the number of chest radiographs in mechanically ventilated adults.
152:JC3-JC3.
2010
-
Risk for postoperative venous thromboembolism in women was increased for ≥ 12 weeks and varied by type of surgery.
152:JC3-JC3.
2010
-
Adding revascularization to medical therapy did not improve renal function in atherosclerotic renal artery stenosis.
152:JC2-JC2.
2010
-
Either cholesterol or apolipoprotein levels can be used to determine risk for CVD; triglycerides are not useful.
152:JC2-JC2.
2010
-
Review: Neuraminidase inhibitors relieve influenza symptoms and reduce laboratory-confirmed influenza in healthy adults.
152:JC2-JC2.
2010
-
Glatiramer acetate delayed conversion to multiple sclerosis in patients with clinically isolated syndrome.
152:JC1-JC1.
2010
-
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding.
152:101-101.
2010
-
Guidelines and Conflicts of Interest.
153:422-422.
2010
-
The vexing problem of guidelines and conflict of interest: a potential solution.
152:738-741.
2010
-
A Mediterranean-style diet reduced need for glucose-lowering drugs more than a low-fat diet in type 2 diabetes.
151:JC6-JC6.
2009
-
New and underutilized features of ACP Journal Club PLUS and ACPJC.org: stellar articles, searches, and succinct synopses of the principles and practice of “personalized” evidence-based medicine.
151:JC6-JC6.
2009
-
Sensitive cardiac troponin assays were more accurate than a standard troponin assay for early diagnosis of AMI.
151:JC6-JC6.
2009
-
Systematic Review: Family History in Risk Assessment for Common Diseases.
151:878-878.
2009
-
Systematic review: family history in risk assessment for common diseases..
151:878-885.
2009
-
Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation.
151.
2009
-
Percutaneous closure of the left atrial appendage was noninferior to warfarin in atrial fibrillation.
151:JC5-JC5.
2009
-
The tough math of evidence-based health care: E × KT2 = ROI.
151:JC5-JC5.
2009
-
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia.
151:622-622.
2009
-
Correction: Predicting Deep Venous Thrombosis in Pregnancy.
151:516-516.
2009
-
Redundant Data in the Meta-analysis onHelicobacter pyloriEradication.
151:513-513.
2009
-
3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA.
151.
2009
-
Accessing preappraised evidence: fine-tuning the 5S model into a 6S model.
151.
2009
-
Accessing preappraised evidence: fine-tuning the 5S model into a 6S model.
151:JC3-JC3.
2009
-
Review: 3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA.
151:JC3-JC3.
2009
-
Vitamin K to Correct Overanticoagulation.
151:435-435.
2009
-
Comparing the USPSTF and GRADE Approaches to Recommendations.
151:363-363.
2009
-
Positron Emission Tomography Plus Computed Tomography for Staging Early Lung Cancer.
151:I-I.
2009
-
Positron Emission Tomography in Staging Early Lung Cancer.
151:221-221.
2009
-
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
151:264-264.
2009
-
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration.
151:W-W.
2009
-
Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?.
151:85-85.
2009
-
The devil is in the details...or not? a primer on individual patient data meta-analysis.
151.
2009
-
The devil is in the details…or not? A primer on individual patient data meta-analysis.
151:JC1-JC1.
2009
-
Effect of Telmisartan on Renal Outcomes.
151:1-1.
2009
-
“Pragmatic” clinical trials: from whose perspective?.
150:JC6-JC6.
2009
-
Composite Outcomes Can Distort the Nature and Magnitude of Treatment Benefits in Clinical Trials.
150:566-566.
2009
-
Aspirin for Prevention and Treatment of Cardiovascular Disease.
150:414-414.
2009
-
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding.
150:379-379.
2009
-
Prednisolone, but not valacyclovir, reduced time to complete recovery of facial-nerve function in Bell palsy.
150:JC3-JC3.
2009
-
What does it take to put an ugly fact through the heart of a beautiful hypothesis?.
150:JC3-JC3.
2009
-
Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin.
150:293-293.
2009
-
Telmisartan did not prevent recurrent stroke or major cardiovascular events.
150:JC2-JC2.
2009
-
A single measure of urinary neutrophil gelatinase–associated lipocalin was accurate for diagnosing acute kidney injury.
149:JC6-JC6.
2008
-
GRADE: assessing the quality of evidence for diagnostic recommendations.
149:JC6-JC6.
2008
-
Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis.
149:698-698.
2008
-
Evidence in context: One person's poison is another's acceptable risk.
149:JC5-JC5.
2008
-
Review: Anticoagulation with INRs < 2 or between 3 and 5 increases risk for thromboembolic or hemorrhagic events.
149:JC5-JC5.
2008
-
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-analyses.
149:596-596.
2008
-
Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses (Annals of Internal Medicine (2008) 149, (219)).
149:596.
2008
-
Systematic Review: d-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism.
149:481-481.
2008
-
In response.
149:359-360.
2008
-
The Importance of Measuring Executive Function When Studying the Effects of Cognition-Enhancing Agents.
149:359-359.
2008
-
Prognosis after West Nile Virus Infection.
149:232-232.
2008
-
Why A-level evidence does not make it to clinicians' A-lists: the case of thromboprophylaxis in medical patients.
149:JC2-JC2.
2008
-
Correction: Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses.
149:219-219.
2008
-
Age, sex, and functional impairment predicted risk for mortality in incident dementia at 14 years.
149:JC1-JC1.
2008
-
Evidence-based medicine targets the individual patient. Part 2: Guides and tools for individual decision-making.
149:JC1-JC1.
2008
-
Evidence-based medicine targets the individual patient. Part 1: How clinicians can use study results to determine optimal individual care.
148:JC4-JC4.
2008
-
Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis.
148:JC4-JC4.
2008
-
Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier.
148:JC4-JC4.
2008
-
Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease.
148:JC4-JC4.
2008
-
Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development.
148:563-563.
2008
-
Guideline Adaptation: An Appealing Alternative to De Novo Guideline Development.
148:564-564.
2008
-
Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians.
148:370-370.
2008
-
Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline.
148:379-379.
2008
-
The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism.
147:766-766.
2007
-
Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin.
147:671-671.
2007
-
In response.
147:671.
2007
-
Anticoagulant Prophylaxis for Hospitalized Medical Patients.
147:524-524.
2007
-
In response.
147:524.
2007
-
Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection.
147:400-400.
2007
-
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes.
147:304-304.
2007
-
In response.
147:281-282.
2007
-
Rituximab for Patients with Idiopathic Thrombocytopenic Purpura.
147:281-281.
2007
-
Surveillance for Hospital Outbreaks of Invasive Group A Streptococcal Infections in Ontario, Canada, 1992 to 2000.
147:234-234.
2007
-
A Red Blood Cell Agglutination d-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy.
147:165-165.
2007
-
Ethical Issues in Stopping Randomized Trials Early Because of Apparent Benefit.
146:878-878.
2007
-
When My Father Died.
146:893-893.
2007
-
Homocysteine-Lowering Therapy and Risk for Venous Thromboembolism.
146:761-761.
2007
-
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients.
146:278-278.
2007
-
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin.
146:184-184.
2007
-
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura.
146:25-25.
2007
-
Interval versus Continuous High-Intensity Exercise in Chronic Obstructive Pulmonary Disease.
145:816-816.
2006
-
Meta-Analysis: Risk for Hypertension in Living Kidney Donors.
145:185-185.
2006
-
An Evaluation of d-Dimer in the Diagnosis of Pulmonary Embolism.
144:812-812.
2006
-
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency.
144:673-673.
2006
-
Plasma Exchange When Myeloma Presents as Acute Renal Failure.
143:777-777.
2005
-
Immune Thrombocytopenia Associated with Efalizumab Therapy for Psoriasis.
143:761-761.
2005
-
Use of a Clinical Prediction Score in Patients with Suspected Deep Venous Thrombosis: Two Steps Forward, One Step Back?.
143:140-140.
2005
-
Clinical Experience and Quality of Health Care.
143:85-85.
2005
-
Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness.
142:1066-1066.
2005
-
Challenges in systematic reviews that evaluate drug efficacy or effectiveness.
142:1066-1072.
2005
-
A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis: d-Dimer Testing Compared with Repeated Ultrasonography.
142:490-490.
2005
-
Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death.
142:510-510.
2005
-
Decisions about Treating Community-Acquired Pneumonia.
142:215-215.
2005
-
Glycemia and Risk for Cardiovascular Disease.
142:227-227.
2005
-
Glycemia and Risk for Cardiovascular Disease.
142:227-227.
2005
-
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation.
141:653-653.
2004
-
Glycosylated Hemoglobin: Finally Ready for Prime Time as a Cardiovascular Risk Factor.
141:475-475.
2004
-
Low-Molecular-Weight Heparin for Pulmonary Embolism.
141:407-407.
2004
-
Low-Molecular-Weight Heparin for Pulmonary Embolism.
141:407-407.
2004
-
Evidence-Based Clinical Practice Guideline for the Prevention of Ventilator-Associated Pneumonia.
141:305-305.
2004
-
Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding.
141:78-78.
2004
-
Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding.
141:80-80.
2004
-
Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study.
140:857-857.
2004
-
Suboptimal Monitoring and Dosing of Unfractionated Heparin.
140:582-582.
2004
-
Randomized Trial of Warfarin Nomograms.
140:488-488.
2004
-
Randomized Trial of Warfarin Nomograms.
140:490-490.
2004
-
Randomized trial of warfarin nomograms..
140:490-491.
2004
-
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism.
140:175-175.
2004
-
Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism.
139:893-893.
2003
-
Which Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Benefit from Noninvasive Positive-Pressure Ventilation?.
138:861-861.
2003
-
A Diagnostic Strategy Involving a Quantitative Latex d-Dimer Assay Reliably Excludes Deep Venous Thrombosis.
138:787-787.
2003
-
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin.
138:720-720.
2003
-
Oral Vitamin K for Warfarin-Associated Coagulopathy.
138:611-611.
2003
-
Oral vitamin K for warfarin-associated coagulopathy..
138:610-611.
2003
-
Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System.
138:128-128.
2003
-
Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy.
137:734-734.
2002
-
Colloid Use in the Critically Ill.
137:370-370.
2002
-
Colloid Use in the Critically Ill.
137:370-370.
2002
-
Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy.
137:251-251.
2002
-
Questioning the Treatment of Venous Thromboembolism.
137:144-144.
2002
-
Questioning the Treatment of Venous Thromboembolism.
137:145-145.
2002
-
Abciximab plus stenting reduced coronary events in patients with acute myocardial infarction.
136:89-89.
2002
-
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria.
136:82-82.
2002
-
Cardiovascular Outcomes and Renal Disease.
136:633-633.
2002
-
Cardiovascular Outcomes and Renal Disease.
136:634-634.
2002
-
The Role of High-Dose Chemotherapy and Stem-Cell Transplantation in Patients with Multiple Myeloma: A Practice Guideline of the Cancer Care Ontario Practice Guidelines Initiative.
136:619-619.
2002
-
Helicobacter pylori Eradication Therapy for Nonulcer Dyspepsia.
136:555-555.
2002
-
Chemotherapy for Older Patients with Newly Diagnosed, Advanced-Stage, Aggressive-Histology Non-Hodgkin Lymphoma.
136:144-144.
2002
-
Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous Thrombosis.
135:589-589.
2001
-
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis.
135:502-502.
2001
-
Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy.
135:412-412.
2001
-
Colloid Use for Fluid Resuscitation: Evidence and Spin.
135:205-205.
2001
-
Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment and d-dimer Testing.
135:108-108.
2001
-
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial.
134:629-629.
2001
-
Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective.
134:409-409.
2001
-
Erythropoietin with Iron Supplementation To Prevent Allogeneic Blood Transfusion in Total Hip Joint Arthroplasty.
133:845-845.
2000
-
Effect of a Preoperative Intervention on Preoperative and Postoperative Outcomes in Low-Risk Patients Awaiting Elective Coronary Artery Bypass Graft Surgery.
133:253-253.
2000
-
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement.
132:853-853.
2000
-
Homocyst(e)ine and Cardiovascular Disease.
132:676-676.
2000
-
Homocyst(e)ine and Cardiovascular Disease.
132:676-676.
2000
-
Use of Statins and Fibrates in Hyperlipidemic Patients with Neuromuscular Disorders.
132:418-418.
2000
-
Erratum: Sensitivity and specificity of a rapid whole-blood assay for D- dimer in the diagnosis of pulmonary embolism (Annals of Internal Medicine (1998) 129 (1006-1011)).
132:247.
2000
-
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism (vol 129, pg 1006, 1998).
132:247-247.
2000
-
Systemic Amyloidosis Presenting with Angina Pectoris.
131:838-838.
1999
-
Interpreting, Integrating, and Individualizing Evidence about the Prevention of Diabetic Nephropathy.
131:707-707.
1999
-
Clinical Utility of a Rapid Whole-Bloodd-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis.
131:417-417.
1999
-
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence.
131:363-363.
1999
-
Ventilator-Associated Pneumonia in Critically Ill Patients.
130:1028-1028.
1999
-
Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism.
129:1006-1006.
1998
-
The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism.
129:1044-1044.
1998
-
Use of a Clinical Model for Safe Management of Patients with Suspected Pulmonary Embolism.
129:997-997.
1998
-
A Survey of Provider Experiences and Perceptions of Preferential Access to Cardiovascular Care in Ontario, Canada.
129:567-567.
1998
-
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients.
129:433-433.
1998
-
Erratum: Misaligned table (Annals of Internal Medicine (1998) 128 (665- 677)).
129:425.
1998
-
The Ineffectiveness of Immunosuppressive Therapy in Lymphocytic Myocarditis: An Overview.
129:317-317.
1998
-
Coenzyme A Reductase Inhibitors and Stroke.
129:161-161.
1998
-
Coenzyme A Reductase Inhibitors and Stroke.
129:162-162.
1998
-
Noninvasive Diagnosis of Deep Venous Thrombosis.
128:663-663.
1998
-
Locating and Appraising Systematic Reviews.
128:322-322.
1998
-
Locating and Appraising Systematic Reviews.
128:323-323.
1998
-
Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery.
128:270-270.
1998
-
Effect of HMGcoA Reductase Inhibitors on Stroke.
128:89-89.
1998
-
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia.
127:804-804.
1997
-
Selecting and Appraising Studies for a Systematic Review.
127:531-531.
1997
-
Antileukotrienes in the Treatment of Asthma.
127:472-472.
1997
-
Reply: Warfarin: Less May Be Better.
127:333-333.
1997
-
The Relation between Systematic Reviews and Practice Guidelines.
127:210-210.
1997
-
Splenectomy for Relapsing Thrombotic Thrombocytopenic Purpura.
126:915-915.
1997
-
Locating and Appraising Systematic Reviews.
126:532-532.
1997
-
Dietary Calcium and Blood Pressure.
126:492-492.
1997
-
Systematic Reviews: Critical Links in the Great Chain of Evidence.
126:389-389.
1997
-
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions.
126:376-376.
1997
-
Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology.
126:319-319.
1997
-
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy.
126:133-133.
1997
-
Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura.
125:294-294.
1996
-
Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity.
125:183-183.
1996
-
The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data (vol 123, pg 860, 1995).
124:934-934.
1996
-
Once-Daily Aminoglycoside Dosing in Immunocompetent Adults.
124:717-717.
1996
-
The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data.
123:860-860.
1995
-
Endoscopic Ligation Compared with Sclerotherapy for Treatment of Esophageal Variceal Bleeding.
123:280-280.
1995
-
Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura.
122:569-569.
1995
-
Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery.
122:47-47.
1995
-
Interactions of Warfarin with Drugs and Food.
121:676-676.
1994
-
Analyzing Computer-based Decision Support Systems.
121:469-469.
1994
-
Can Bruits Distinguish High-Grade from Moderate Symptomatic Carotid Stenosis?.
120:633-633.
1994
-
Can bruits distinguish high-grade from moderate symptomatic carotid stenosis? The North American Symptomatic Carotid Endarterectomy Trial..
120:633-637.
1994
-
Thrombocytopenia and Illicit Drug Use.
120:693-693.
1994
-
Heart rate, ischemic heart disease, and sudden cardiac death.
120:48.
1994
-
Glycogen Storage Disease in Adults.
120:218-218.
1994
-
Effects of Computer-based Clinical Decision Support Systems on Clinician Performance and Patient Outcome: A Critical Appraisal of Research.
120:135-135.
1994
-
MONITORING HEPARIN-THERAPY - RESPONSE.
120:170-170.
1994
-
Monitoring Heparin Therapy.
120:169-169.
1994
-
Aspirin and warfarin after heart-valve replacement.
120:3.
1994
-
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty.
119:1105-1105.
1993
-
Screening for Abdominal Aortic Aneurysm in Men Ages 60 to 80 Years: A Cost-Effectiveness Analysis.
119:411-411.
1993
-
Impedance Plethysmography and DVT Diagnosis.
119:246-246.
1993
-
Establishing a Therapeutic Range for Heparin Therapy.
119:104-104.
1993
-
Measuring Health-Related Quality of Life.
118:622-622.
1993
-
Incidence of Postpartum Thyroid Dysfunction in Patients with Type I Diabetes Mellitus.
118:419-419.
1993
-
Eliciting Patient Preferences.
118:76-76.
1993
-
Eliciting patient preferences..
118:76.
1993
-
Limitations of Impedance Plethysmography in the Diagnosis of Clinically Suspected Deep-Vein Thrombosis.
118:25-25.
1993
-
Nephrotoxicity of high- and low-osmolality contrast media: A meta-analysis.
119:74.
1993
-
On the clinically important difference [1].
118:94.
1993
-
Salmeterol or albuterol for mild-to-moderate asthma.
118:83.
1993
-
Enalapril for asymptomatic reduced left ventricular ejection fraction.
118:3.
1992
-
Prevention of UV-light-induced herpes labialis by sunscreen.
116:82.
1992
-
Thrombosis in Antithrombin-III Deficiency.
117:875-875.
1992
-
Prevention of first bleeding from varices: A meta-analysis.
117:66.
1992
-
A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke.
117:353-353.
1992
-
Subcutaneous compared with intravenous heparin for deep vein thrombosis..
117:266.
1992
-
A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer.
117:53-53.
1992
-
SUBGROUP ANALYSES - RESPONSE.
117:93-94.
1992
-
Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia.
116:977-977.
1992
-
Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy.
116:731-731.
1992
-
Thrombosis in Antithrombin-III-deficient Persons.
116:754-754.
1992
-
CLINICAL-TRIALS - TO TERMINATE OR NOT TO TERMINATE - REPLY.
116:700-700.
1992
-
A Consumer's Guide to Subgroup Analyses.
116:78-78.
1992
-
Gastric pH and nosocomial pneumonia: A meta-analysis.
116:8.
1992
-
On the clinically important difference.
117.
1992
-
Prevention of first bleeding from varices: A meta-analysis.
117:66.
1992
-
Quinidine-related mortality in ventricular arrhythmias: A meta-analysis.
116:45.
1992
-
Respiratory training for chronic airflow limitation: A meta-analysis.
117:49.
1992
-
Silent myocardial ischemia in patients with myocardial infarction.
117:25.
1992
-
Symptoms of hypoglycemia with human versus porcine insulin.
116:33-34.
1992
-
β-Agonists and the risk for death and near-death from asthma.
117:26.
1992
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
115:67.
1991
-
How Should Results from Completed Studies Influence Ongoing Clinical Trials?.
115:818-818.
1991
-
Enalapril for increased survival in congestive heart failure.
115:67.
1991
-
Stroke Prevention in Nonvalvular Atrial Fibrillation.
115:727-727.
1991
-
aspirin to prevent pregnancy-induced hypertension: A meta-analysis.
115:80.
1991
-
LMW Heparin for Deep Vein Thrombosis.
115:231-231.
1991
-
LOW-MOLECULAR-WEIGHT HEPARIN FOR DEEP-VEIN THROMBOSIS.
115:232-232.
1991
-
Prevention of Deep Vein Thrombosis after Elective Hip Surgery.
114:545-545.
1991
-
3-Year effects of intensified insulin on hypoglycemia.
114:84.
1991
-
Effectiveness of a geriatric day hospital.
115:40.
1991
-
Iron deficiency in the elderly: The diagnostic process.
115:54.
1991
-
t-PA and APSAC for acute myocardial infarction: A meta-analysis.
114:36.
1991
-
Loose Connections between Peer-Reviewed Clinical Journals and Clinical Practice.
113:724-724.
1990
-
STRUCTURED ABSTRACTS - RESPONSE.
113:722-723.
1990
-
More Informative Abstracts Revisited.
113:69-69.
1990
-
Then-of-1 Randomized Controlled Trial: Clinical Usefulness.
112:293-293.
1990
-
Online Access to MEDLINE in Clinical Settings.
112:78-78.
1990
-
MEDICAL THERAPY FOR CHRONIC CONGESTIVE HEART-FAILURE - REPLY.
111:768-769.
1989
-
Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?.
111:1-1.
1989
-
Medical Therapy for Chronic Congestive Heart Failure.
110:758-758.
1989
-
Screening for Endometrial Cancer: Is It Effective?.
110:177-177.
1989
-
Campylobacter pylori Infection.
109:925-925.
1988
-
Pulmonary Hypertension in Hemophilia.
109:759-759.
1988
-
Somatostatin Treatment for Cryptosporidial Diarrhea in a Patient with the Acquired Immunodeficiency Syndrome (AIDS).
108:708-708.
1988
-
ALTERNATE METHODS OF HEPARIN ADMINISTRATION.
108:306-306.
1988
-
Increased Neutrophil Elastase Activity in Cigarette Smokers.
107:680-680.
1987
-
Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis.
107:441-441.
1987
-
Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung Cancer.
107:451-451.
1987
-
Bicarbonate in Severe Lactic Acidosis.
107:258-258.
1987
-
Health Economics: An Introduction for Clinicians.
107:88-88.
1987
-
HEPARIN IN ACUTE PARTIAL STABLE STROKE - RESPONSE.
106:782-782.
1987
-
PAPER CHASE - RESPONSE.
106:783-783.
1987
-
A Proposal for More Informative Abstracts of Clinical Articles.
106:598-598.
1987
-
Correction: How to Keep Up with the Medical Literature.
106:174-174.
1987
-
Canadian Cancer Care: Organizational Models.
105:932-932.
1986
-
How to Keep Up with the Medical Literature: VI. How to Store and Retrieve Articles Worth Keeping.
105:978-978.
1986
-
Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke: A Randomized Controlled Trial.
105:825-825.
1986
-
Intravenous heparin for the prevention of stroke progression in acute partial stable stroke..
105:825-828.
1986
-
How to Keep Up with the Medical Literature: V. Access by Personal Computer to the Medical Literature.
105:810-810.
1986
-
How to Keep Up with the Medical Literature: IV. Using the Literature to Solve Clinical Problems.
105:636-636.
1986
-
How to Keep Up with the Medical Literature: III. Expanding the Number of Journals You Read Regularly.
105:474-474.
1986
-
Searching the Medical Literature.
105:472-472.
1986
-
How to Keep Up with the Medical Literature: II. Deciding Which Journals to Read Regularly.
105:309-309.
1986
-
Seroconversion After Hepatitis B Vaccination.
105:293-293.
1986
-
How to Keep Up with the Medical Literature: I. Why Try to Keep Up and How to Get Started.
105:149-149.
1986
-
Computer Searching of the Medical Literature.
104:723-723.
1986
-
COMPUTER SEARCHING OF THE MEDICAL LITERATURE - REPLY.
104:583-583.
1986
-
ONLINE SYSTEMS FOR SEARCHING MEDLINE - RESPONSE.
104:442-443.
1986
-
Computer Searching of the Medical Literature.
103:812-812.
1985
-
Platelet-Aggregating Factor in Thrombotic Thrombocytopenic Purpura.
102:560-560.
1985
-
Malignant Lymphoma Presenting as Kaposi's Sarcoma in a Homosexual Man with the Acquired Immunodeficiency Syndrome.
102:338-338.
1985
-
Diagnostic Efficacy of Impedance Plethysmography for Clinically Suspected Deep-Vein Thrombosis.
102:21-21.
1985
-
Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic Purpura.
101:589-589.
1984
-
Lidocaine Therapy with an Exponentially Declining Infusion.
101:632-632.
1984
-
Choice of Platelet Anticoagulants.
100:613-613.
1984
-
Heparin-Associated Thrombocytopenia.
100:535-535.
1984
-
HEPARIN-ASSOCIATED THROMBOCYTOPENIA - RESPONSE.
101:280-280.
1984
-
Management of the Pregnant Patient with Idiopathic Thrombocytopenic Purpura.
99:796-796.
1983
-
Pulmonary Angiography, Ventilation Lung Scanning, and Venography for Clinically Suspected Pulmonary Embolism with Abnormal Perfusion Lung Scan.
98:891-891.
1983
-
Effect of Digoxin on Right Ventricular Function in Severe Chronic Airflow Obstruction.
95:283-283.
1981
-
Replacement of Venography in Suspected Venous Thrombosis by Impedance Plethysmography and125I-Fibrinogen Leg Scanning.
94:12-12.
1981
-
Gentamicin Hemodialysis.
92:709-709.
1980
-
Tamoxifen and Metastatic Breast Cancer.
89:721-721.
1978
-
Tamoxifen and Hypercalcemia.
89:423-423.
1978
-
Comparison of Chemical Composition of Peritoneal Fluid and Serum.
89:67-67.
1978
-
Drinking Water Hardness and Urolithiasis.
88:513-513.
1978
-
Tamoxifen and metastatic breast cancer.
89:721-722.
1978
-
The Burlington Randomized Trial of the Nurse Practitioner: Health Outcomes of Patients.
80:137-137.
1974
-
Thrombolytic Therapy and Fatal Pulmonary Emboli.
75:140-140.
1971
-
Death and Disability in Drug Addiction and Abuse.
67:205-205.
1967
-
THE MANAGEMENT OF BILIARY TRACT DISORDERS IN PATIENTS WITH HEART DISEASE.
39:484-484.
1953
-
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
2003
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)